AX Pharmaceutical Corp
- Manufacturer
- AX Pharmaceutical Corp
- Effective date
- 2018-07-27
- Label type
- BULK INGREDIENT
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:49:03
Label at a glance#
ProductAX Pharmaceutical Corp
Active ingredientPHENTOLAMINE MESYLATE
Label structure1 sections
Label contents#
Full prescribing information#
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 217cde05-1bd7-4d5d-bae5-725392a5286a | Product name | 1 | 20250623 |
| 52987bfd-5e19-a3f5-c33e-e68c5f75fe88 | Product name | 2 | 20170815 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62157-641-01 | AX Pharmaceutical Corp | 500 g in 1 JAR | POWDER | 500 | 1 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- AX Pharmaceutical Corp
- PHENTOLAMINE MESYLATE
- PHENTOLAMINE
- WATER
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 62157-641 | 62157-641-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| PHENTOLAMINE MESYLATE | Y7543E5K9T | ACTIB |
| WATER | 059QF0KO0R | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ryzumvi | PHENTOLAMINE MESYLATE | Oyster Point Pharma, Inc. | 96bb1e53-c2cc-4e60-a21a-db0269c371bf | 2026-03-15 | Warnings, Adverse reactions | PHENTOLAMINE MESYLATE |
| PHENTOLAMINE MESYLATE | PHENTOLAMINE MESYLATE | Precision Dose Inc. | e146c7ee-d2fa-433c-8768-0945e4ff0990 | 2024-08-19 | Warnings, Adverse reactions | PHENTOLAMINE MESYLATE |
| Phentolamine Mesylate | PHENTOLAMINE MESYLATE | Hikma Pharmaceuticals USA Inc. | ed6c506c-5535-4b7c-ae1a-d63f09d796c9 | 2024-03-13 | Warnings, Adverse reactions | PHENTOLAMINE MESYLATE |
| Oraverse | PHENTOLAMINE MESYLATE | Septodont, Inc. | 4025cf98-ea87-4531-b0fc-6283c84f63f3 | 2018-12-05 | Warnings, Adverse reactions | PHENTOLAMINE MESYLATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
